| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.073 | 0.2 |